Virginia Belsúe

Navarre Institute of Health Research — Spain

Immunology and Microbiology · Life Sciences

9h-index781citations28works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(8), Cancer Immunotherapy and Biomarkers(6), Hepatitis C virus research(5), Immune Cell Function and Interaction(4), T-cell and B-cell Immunology(3)

Publications28 total

Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA
Theranostics·2026Open Access
848 The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis
Regular and Young Investigator Award Abstracts·2025Open Access
Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Nature·2025Open Access
The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis
OncoImmunology·2025Open Access
Intratumoral administration of Hibiscus sabdariffa-derived anthocyanins exerts potent antitumor effects in murine cancer models
Frontiers in Immunology·2025· 4 citedOpen Access
Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis
Journal of Nanobiotechnology·2025· 3 citedOpen Access
Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth
Frontiers in Immunology·2025· 2 citedOpen Access
Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice Models
Methods in molecular biology·2025
356 Intracavitary adoptive transfer of tumor-specific T lymphocytes modified with IL-33 mRNA transiently expressed for the treatment of peritoneal carcinomatosis model
Regular and Young Investigator Award Abstracts·2024Open Access
Tumor slice culture system for ex vivo immunotherapy studies
Methods in cell biology·2024· 2 cited
Peritoneal carcinomatosis in mouse models
Methods in cell biology·2024
Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
Frontiers in Pharmacology·2021· 8 citedOpen Access
Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor
Biomedicines·2021· 10 citedOpen Access
Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1
British Journal of Cancer·2021· 6 citedOpen Access
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Nature·2019· 467 citedOpen Access
Abstract LB-151: Prophylactic TNFα blockade unplugs toxicity and efficacy in immunotherapy anti-PD-1 + anti-CTLA-4 combinations
Cancer Research·2018
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation
The Journal of Immunology·2015· 58 cited
Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination
OncoImmunology·2015· 20 citedOpen Access
Immune monitoring of immunosuppression withdrawal of liver transplant recipients
Transplant Immunology·2015· 22 cited
Helper cell-independent antitumor activity of potent CD8<sup>+</sup>T cell epitope peptide vaccines is dependent upon CD40L
OncoImmunology·2013· 3 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Pedro Berraondo(13), Pablo Sarobe(11), Juan José Lasarte(11), Fernando Aranda(11), Nuria Ardaiz(10), Celia Gomar(10), Leire Arrizabalaga(8), Ignacio Melero(6), Francisco Borrás‐Cuesta(6), Aline Risson(6), José Ignacio Riezu‐Boj(5), Jesús Prìeto(5), Noëlia Casares(5), Claudia Augusta Di Trani(5), Marta Ruiz(4), Nancy Díaz‐Valdés(4), Ángela Bella(4), Elísabeth Pérez-Ruiz(3), Luna Minute(3), Maite Álvarez(3)